BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 758043)

  • 61. Relationship between semen quality improvement after varicocelectomy and preoperative levels of hypophyseal and gonadal hormones.
    Bablok L; Czaplicki M; Fracki S; Marianowski L; Borkowski A
    Int Urol Nephrol; 1997; 29(3):345-9. PubMed ID: 9285309
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
    Seppälä M; Unnérus HA; Hirvonen E; Ranta T
    J Clin Endocrinol Metab; 1976 Aug; 43(2):474-7. PubMed ID: 950375
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.
    Berezin M; Olchovsky D; Pines A; Tadmor R; Lunenfeld B
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1220-3. PubMed ID: 6436289
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationship of changes in serum concentrations of prolactin and testosterone during dopaminergic modulation in males.
    Nakagawa K; Obara T; Matsubara M; Kubo M
    Clin Endocrinol (Oxf); 1982 Oct; 17(4):345-52. PubMed ID: 6814794
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma.
    Tomić R; Ljungberg B; Damber JE
    Scand J Urol Nephrol; 1988; 22(1):15-8. PubMed ID: 2968646
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The influence of chronic exposure to low frequency pulsating magnetic fields on concentrations of FSH, LH, prolactin, testosterone and estradiol in men with back pain.
    Woldanska-Okonska M; Karasek M; Czernicki J
    Neuro Endocrinol Lett; 2004 Jun; 25(3):201-6. PubMed ID: 15349086
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
    Porcaro AB; Ghimenton C; Petrozziello A; Migliorini F; Romano M; Sava T; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C; Comunale L
    Anticancer Res; 2011 Nov; 31(11):3913-20. PubMed ID: 22110219
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of bromocriptine in the polycystic ovary syndrome.
    Spruce BA; Kendall-Taylor P; Dunlop W; Anderson AJ; Watson MJ; Cook DB; Gray C
    Clin Endocrinol (Oxf); 1984 Apr; 20(4):481-8. PubMed ID: 6424978
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Comparative study of cyproterone acetate and estramustine phosphate on the plasma levels of testosterone and gonadotrophic hormones in adenocarcinoma of the prostate].
    Alfonso Sánchez M; Pérez Herrero F; Urrutia Avisrror M; Vega Wong J; Lago Montero A
    Actas Urol Esp; 1986; 10(2):111-6. PubMed ID: 2942009
    [No Abstract]   [Full Text] [Related]  

  • 71. Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men.
    Ortega E; Ruiz E; Mendoza MC; Martin-Andres A; Osorio C
    Experientia; 1979 Jun; 35(6):844-5. PubMed ID: 89045
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prolactin and pituitary gonadotropin values and responses to acute luteinizing hormone-releasing hormone (LHRH) challenge in patients having long-term treatment with a depot LHRH analogue.
    Mahler C; Verhelst J; Chaban M; Denis L
    Cancer; 1991 Feb; 67(3):557-9. PubMed ID: 1824680
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Carcinoma of the prostate: relationship of pretreatment hormone levels to survival.
    Harper ME; Pierrepoint CG; Griffiths K
    Eur J Cancer Clin Oncol; 1984 Apr; 20(4):477-82. PubMed ID: 6426967
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Plasma testosterone: a sound criterion of the effectiveness of hormonal treatment of prostatic carcinoma].
    Maleeva A; Tsvetkov M; Kekhaĭova M
    Vutr Boles; 1980; 19(3):42-6. PubMed ID: 6771918
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea an the response to bromocriptine therapy.
    Moult PJ; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):153-62. PubMed ID: 6802531
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D; Smith S; Zacur H
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Bromocriptine and prostatic carcinoma: testosterone metabolism in relation to tumor grading (author's transl)].
    Jacobi GH; Kurth KH; Altwein JE
    Urologe A; 1979 Mar; 18(2):91-8. PubMed ID: 433016
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of tamoxifen on the levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), 17 beta-oestradiol (E2), total and free testosterone (T) and total and free dihydrotestosterone (DHT) in blood of patients with benign prostatic hyperplasia.
    Stahl F; Schnorr D; Rohde W; Poppe I; Geier T; Dörner G
    Exp Clin Endocrinol; 1983 Jul; 82(1):21-8. PubMed ID: 6193975
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of naloxone infusion on plasma levels of LH, FSH, and in addition TSH and prolactin in males, before and after oestrogen or anti-oestrogen treatment.
    van Bergeijk L; Gooren LJ; van Kessel H; Sassen AM
    Horm Metab Res; 1986 Sep; 18(9):611-5. PubMed ID: 3096859
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The effect of long-term prazosin treatment on plasma follitropin (FSH), lutropin (LH), prolactin, estradiol and testosterone concentration in male patients with essential hypertension].
    Wiecek A; Kokot F; Zukowska-Szczechowska E
    Pol Arch Med Wewn; 1993 Feb; 89(2):125-35. PubMed ID: 8502593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.